Masimo (MASI) Amortization of Deferred Charges (2022 - 2026)
Masimo's (MASI) quarterly Amortization of Deferred Charges came in at $300000.0 in Q2 2026, down 40.0% year-on-year from $500000.0 in Q2 2025, and down 57.14% quarter-over-quarter from $700000.0 in Q1 2026.
Masimo (MASI) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Masimo's Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $300000.0 for Q2 2026.
- On a quarterly basis, Amortization of Deferred Charges fell 40.0% year-over-year to $300000.0 in Q2 2026; TTM through Apr 2026 was $2.8 million, a 47.37% increase from a year earlier, with the FY2026 full-year figure at $3.0 million, up 57.89% from the prior year.
- Amortization of Deferred Charges slipped to $300000.0 in Q2 2026 per MASI's latest filing, from $700000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $1.4 million in Q3 2025 and bottomed at $300000.0 in Q2 2026.
- The 5-year median for Amortization of Deferred Charges is $500000.0 (2022), against an average of $566666.7.
- Across the five-year window, Amortization of Deferred Charges plunged 44.44% in 2023 and jumped 180.0% in 2025, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then changed by 0.0% to $500000.0 in 2024, then surged by 180.0% to $1.4 million in 2025, then tumbled by 78.57% to $300000.0 in 2026.
- Per Business Quant, the three latest MASI Amortization of Deferred Charges figures stand at $300000.0 (Q2 2026), $700000.0 (Q1 2026), and $1.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 300,000.00 |
| Apr 4, 2026 | 300,000.00 |
| Jan 3, 2026 | 700,000.00 |
| Jan 3, 2026 | 700,000.00 |
| Sep 27, 2025 | 1.40 Mn |
| Sep 27, 2025 | 1.40 Mn |
| Jun 28, 2025 | 400,000.00 |
| Jun 28, 2025 | 400,000.00 |
| Mar 29, 2025 | 500,000.00 |
| Mar 29, 2025 | 500,000.00 |
| Dec 28, 2024 | 500,000.00 |
| Dec 28, 2024 | 500,000.00 |
| Sep 28, 2024 | 500,000.00 |
| Sep 28, 2024 | 500,000.00 |
| Jun 29, 2024 | 400,000.00 |
| Jun 29, 2024 | 400,000.00 |
| Mar 30, 2024 | 500,000.00 |
| Mar 30, 2024 | 500,000.00 |
| Dec 30, 2023 | 500,000.00 |
| Dec 30, 2023 | 500,000.00 |